Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05636618
Title Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors ([212-Pb]-VMT)
Acronym [212-Pb]-VMT
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Perspective Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic RECRUITING Jacksonville Florida 32224 United States Details
Biogenix Molecular RECRUITING Miami Florida 33165 United States Details
The University of Chicago RECRUITING Chicago Illinois 60637 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
University of Kentucky RECRUITING Lexington Kentucky 40536 United States Details
Johns Hopkins RECRUITING Baltimore Maryland 21287 United States Details
BAMF Health RECRUITING Grand Rapids Michigan 49503 United States Details
Michigan Health Professionals RECRUITING Troy Michigan 48098 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Washington University RECRUITING Saint Louis Missouri 63110 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field